A Survival God for the Age of Abundance,” Peter H. Diamandis and Steven Kotler explore what it means to be human in a world ...
Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...
In the new trial, researchers will inject the three genes into one eye using a modified virus. Patients will then take an ...
A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...
Morning Overview on MSN
First human trial tests gene therapy aimed at reversing cellular aging
For the roughly 80 million people worldwide living with glaucoma, daily life often means watching the world slowly close in.
India, April 13 -- Life Biosciences, a clinical-stage biotechnology company focused on reversing diseases of aging, has ...
Rather than scrambling to repair itself only after injury occurs, a Korean research team has demonstrated that ...
The field of partial reprogramming is transitioning from successful mouse studies to its first human clinical trials. At the heart of this experiment lies the discovery of Yamanaka ...
Plant cells do not easily abandon their mature identity. In apple, that transformation is especially important because somatic embryogenesis underpins ...
Some jellyfish possess the extraordinary ability to revert their cells back to an earlier developmental stage, effectively ...
Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results